These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8331779)
1. [Clinical studies on ceftriaxone in respiratory tract infections. CTRX Study Group]. Shimada K; Kimura H; Kudoh S; Mohri M; Shiraishi T; Amano Y; Kurashima A; Uzawa T; Hisada T; Nagata T Jpn J Antibiot; 1993 Feb; 46(2):184-91. PubMed ID: 8331779 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficacy of ceftriaxone in acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media. A comparative study with cefotiam as the control]. Baba S; Mori Y; Suzuki K; Unno T; Kawabori S; Yanai T; Nonaka S; Takasaka T; Awataguchi T; Furuuchi I Jpn J Antibiot; 1989 Jan; 42(1):212-47. PubMed ID: 2523493 [TBL] [Abstract][Full Text] [Related]
3. [Clinical and pharmacokinetics studies of ceftriaxone upon 2g once daily administration in respiratory tract infections]. Ishioka S; Yamakido H; Inyaku K; Hasegawa K; Yamakido M; Akagawa T; Kuwabara M; Kodomari Y; Kawamoto M; Arita H Jpn J Antibiot; 1991 Jun; 44(6):605-13. PubMed ID: 1890721 [TBL] [Abstract][Full Text] [Related]
4. [Clinical studies and sputum levels of ceftriaxone once daily administration in respiratory tract infection]. Kuwabara M; Sasaki H; Fukuhara H; Arita H; Inamizu T; Sadamoto K; Kimura T; Yamane K; Shigemoto M; Kawamoto M Jpn J Antibiot; 1989 Apr; 42(4):921-9. PubMed ID: 2671426 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections]. Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335 [TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of ceftriaxone when administered once daily for respiratory tract infections in patients with advanced ages]. Takizawa S; Yanase K; Hashizume I; Kasamatsu N; Tachibana A; Ogisu N; Okazawa M Jpn J Antibiot; 1992 Jun; 45(6):681-6. PubMed ID: 1507399 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy of ceftriaxone against infections in the field of obstetrics and gynecology]. Chimura T; Morisaki N; Matsuo M Jpn J Antibiot; 1988 Jun; 41(6):641-5. PubMed ID: 3221429 [TBL] [Abstract][Full Text] [Related]
8. [Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections]. Nishio S; Yoshihara H Hinyokika Kiyo; 1988 May; 34(5):937-42. PubMed ID: 3177133 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of ceftriaxone in the treatment of neonatal infections]. Okura K; Yamamoto H; Yamaoka K; Kubo K; Mitsuyoshi I; Haruta T; Kobayashi Y Jpn J Antibiot; 1988 Feb; 41(2):152-64. PubMed ID: 3286924 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation on ceftriaxone in the pediatric field]. Nakazawa S; Satoh H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K Jpn J Antibiot; 1984 Nov; 37(11):2083-101. PubMed ID: 6098703 [TBL] [Abstract][Full Text] [Related]
12. [Single-daily-dose treatment of ceftriaxone for biliary tract infections and bacterial counts in bile]. Tanimura H; Maniwa Y; Okamoto M; Mukaihara S; Takabayashi A; Sato T; Henmi K; Yoshida K; Sawada H Nihon Geka Hokan; 1989 May; 58(3):299-309. PubMed ID: 2619435 [TBL] [Abstract][Full Text] [Related]
13. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone]. Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants]. Motohiro T; Oda K; Aramaki M; Tanaka K; Kawakami A; Shimada Y; Koga T; Tomita S; Sakata Y; Fujimoto T Jpn J Antibiot; 1988 Mar; 41(3):276-305. PubMed ID: 3404647 [TBL] [Abstract][Full Text] [Related]
15. [Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology]. Yamamoto T; Yasuda J; Kanao M; Okada H Jpn J Antibiot; 1984 Dec; 37(12):2355-63. PubMed ID: 6098729 [TBL] [Abstract][Full Text] [Related]
17. [Ceftriaxone as a single agent in empirical therapy of infection in patients with hematologic disorders. Hanshin Infection Study Group]. Kuyama J; Yonezawa T; Kageyama T; Ohyabu H; Kitani T; Taniguchi N; Masaoka T; Shibata H; Yasunaga K; Fujitake H Jpn J Antibiot; 1989 Apr; 42(4):930-7. PubMed ID: 2671427 [TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field]. Sunakawa K; Saitoh N; Adachibara A; Ishizuka Y; Iwata S; Satoh Y; Akita H Jpn J Antibiot; 1984 Nov; 37(11):2102-10. PubMed ID: 6098704 [TBL] [Abstract][Full Text] [Related]
19. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections. Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458 [TBL] [Abstract][Full Text] [Related]
20. [Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology]. Kubota K Jpn J Antibiot; 1984 Dec; 37(12):2406-15. PubMed ID: 6098736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]